Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative Pathogens

Area of Science:

• Microbiology
• Natural Products Chemistry
• Drug Discovery

Background:

• Negamycin is a natural product antibiotic effective against Gram-negative pathogens.
• Understanding its ribosomal binding and inhibition mechanism is key to developing new analogs.
• Previous studies indicated strict structural requirements for negamycin's activity.

Purpose of the Study:

• To explore modifications of negamycin to identify analogs with enhanced antibacterial activity.
• To investigate the structure-activity relationship of negamycin derivatives.
• To assess the potential of negamycin analogs for clinical development.

Main Methods:

• Synthesis of negamycin analogs with modifications at various moieties.
• Evaluation of translation-inhibitory potency and antimicrobial activity.
• Assessment of ribosomal binding conformation and structure-activity relationships.

Main Results:

• Modifications to most parts of negamycin reduced its activity, consistent with its ribosomal binding.
• Substitutions on the N6 amine were well-tolerated.
• N6-(3-aminopropyl)-negamycin (31f) demonstrated a 4-fold increase in antibacterial activity against key pathogens.

Conclusions:

• Negamycin's activity is highly dependent on its core structure.
• The N6 amine is a viable site for modification to improve antibacterial potency.
• N6-(3-aminopropyl)-negamycin is the most potent derivative identified, offering a promising lead for a new class of antibiotics.